Our top pick for
Vistra Corp is an utilities-independent power producers business based in the US. Vistra shares (VST) are listed on the NYSE and all prices are listed in US Dollars. Vistra employs 5,365 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$19.11|
|52-week range||$15.22 - $23.61|
|50-day moving average||$18.12|
|200-day moving average||$17.89|
|Wall St. target price||$25.20|
|Dividend yield||$0.57 (2.91%)|
|Earnings per share (TTM)||$-3.27|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-2.90%|
|1 month (2021-09-24)||8.83%|
|3 months (2021-07-23)||0.05%|
|6 months (2021-04-23)||9.26%|
|1 year (2020-10-23)||-0.88%|
|2 years (2019-10-24)||-29.20%|
|3 years (2018-10-24)||22.14|
|5 years (2016-10-24)||21.88%|
Valuing Vistra stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vistra's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Vistra's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5048. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Vistra's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Vistra's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $498 million.
The EBITDA is a measure of a Vistra's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$11.8 billion|
|Gross profit TTM||$4.6 billion|
|Return on assets TTM||-3.43%|
|Return on equity TTM||-22.52%|
|Market capitalisation||$9.5 billion|
TTM: trailing 12 months
There are currently 11.1 million Vistra shares held short by investors – that's known as Vistra's "short interest". This figure is 15.3% up from 9.6 million last month.
There are a few different ways that this level of interest in shorting Vistra shares can be evaluated.
Vistra's "short interest ratio" (SIR) is the quantity of Vistra shares currently shorted divided by the average quantity of Vistra shares traded daily (recently around 3.8 million). Vistra's SIR currently stands at 2.93. In other words for every 100,000 Vistra shares traded daily on the market, roughly 2930 shares are currently held short.
However Vistra's short interest can also be evaluated against the total number of Vistra shares, or, against the total number of tradable Vistra shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vistra's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Vistra shares in existence, roughly 20 shares are currently held short) or 0.0231% of the tradable shares (for every 100,000 tradable Vistra shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vistra.
Find out more about how you can short Vistra stock.
We're not expecting Vistra to pay a dividend over the next 12 months.
Vistra's shares were split on a 50:1 basis on 8 August 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 50 shares. This wouldn't directly have changed the overall worth of your Vistra shares – just the quantity. However, indirectly, the new 98% lower share price could have impacted the market appetite for Vistra shares which in turn could have impacted Vistra's share price.
Over the last 12 months, Vistra's shares have ranged in value from as little as $15.2159 up to $23.6105. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Vistra's is 0.8955. This would suggest that Vistra's shares are less volatile than average (for this exchange).
Vistra Corp. , together with its subsidiaries, engages in the electricity business in the United States. It operates through six segments: Retail, Texas, East, West, Sunset, and Asset Closure. The company retails electricity and natural gas to residential, commercial, and industrial customers across 20 states in the United States and the District of Columbia. It is also involved in the electricity generation, wholesale energy sales and purchases, commodity risk management, fuel production, and fuel logistics management activities. The company serves approximately 4. 5 million residential, commercial, and industrial customers.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.